Disclaimer: The author of this Investor.News post, which is published by InvestorNews Inc., may or may not be a shareholder of any of the companies mentioned in this column. No company mentioned has sponsored or paid for this content on Investor.News, and InvestorNews Inc. does not accept opt-in payments from advertisers. While InvestorNews Inc. provides digital media services like video interviews and podcasts to advertisers, not all are paid promotions. Any sponsored video interview will be clearly marked in the summary. The author of this piece is not a licensed investment advisor and makes no recommendations to buy, sell, or hold any securities. If the author holds an investment advisor license, this will be stated in their biography. Conduct your own due diligence by reviewing public documents of any company. For our full legal notices and disclaimers, click here click here.
IN8 Member News
-
FendX Announces First Real-World Performance Testing Site for REPELWRAP(TM) Film at Award Winning Giulietta Restaurant
-
Silver Bullet Mines Commences Processing of Third Party Silver Material
-
Xcite Resources Provide Update on Beaver River Uranium Project
-
F3 Announces Revised Bought Deal Private Placement for Gross Proceeds of C$9.0 Million
-
Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting